Literature DB >> 3384900

Endocarditis caused by Capnocytophaga ochracea.

A Y Buu-Hoi1, S Joundy, J F Acar.   

Abstract

Capnocytophaga ochracea is a gram-negative, fusiform bacillus which is part of the normal human oral flora. This organism is often isolated from periodontal lesions of patients with periodontitis and is associated with sepsis in granulocytopenic patients. We report here a case of endocarditis caused by C. ochracea.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3384900      PMCID： PMC266522          DOI： 10.1128/jcm.26.5.1061-1062.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Septicemia due to Capnocytophaga (Bacteroides ocharaceus) in Hodgkin's disease.

Authors:  P C Appelbaum; J O Ballard; M E Eyster
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

2.  Studies of the microbiology of periodontosis.

Authors:  M G Newman; S S Socransky; E D Savitt; D A Propas; A Crawford
Journal:  J Periodontol       Date:  1976-07       Impact factor: 6.993

3.  Capnocytophaga septicemia.

Authors:  A A Haulk; A M Sugar; J L Rushing
Journal:  N Engl J Med       Date:  1980-04-17       Impact factor: 91.245

4.  A neutrophil disorder induced by capnocytophaga, a dental micro-organism.

Authors:  S B Shurin; S S Socransky; E Sweeney; T P Stossel
Journal:  N Engl J Med       Date:  1979-10-18       Impact factor: 91.245

5.  Cervical abscess due to Capnocytophaga ochracea.

Authors:  R Seger; J Kloeti; A von Graevenitz; J Wüst; J Briner; U Willi; H Siegrist
Journal:  Pediatr Infect Dis       Date:  1982 May-Jun

6.  Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1.

Authors:  M G Newman; V L Sutter; M J Pickett; U Blachman; J R Greenwood; V Grinenko; D Citron
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

7.  Synonymy of strains of Center for Disease Control group DF-1 with species of Capnocytophaga.

Authors:  B L Williams; D Hollis; L V Holdeman
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

8.  Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis.

Authors:  C Gandola; T Butler; S Badger; E Cheng; S Beard
Journal:  Arch Intern Med       Date:  1980-06

9.  Capnocytophaga ochracea septicemia.

Authors:  P H Gilligan; L R McCarthy; B K Bissett
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

10.  Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization.

Authors:  S S Socransky; S C Holt; E R Leadbetter; A C Tanner; E Savitt; B F Hammond
Journal:  Arch Microbiol       Date:  1979-07       Impact factor: 2.552
View more
  8 in total

1.  Capnocytophaga lung abscess in a patient with metastatic neuroendocrine tumor.

Authors:  Raghu Thirumala; Urania Rappo; N Esther Babady; Mini Kamboj; Mohit Chawla
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.

Authors:  D L Roscoe; S J Zemcov; D Thornber; R Wise; A M Clarke
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

3.  T lymphocyte disorder after Capnocytophaga ochracea endocarditis.

Authors:  F Gormand; J Etienne; D Rigal; M Bonnard; J Fleurette; J Beaune
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

4.  Development of techniques to genetically manipulate members of the genera Cytophaga, Flavobacterium, Flexibacter, and Sporocytophaga.

Authors:  M J McBride; S A Baker
Journal:  Appl Environ Microbiol       Date:  1996-08       Impact factor: 4.792

5.  In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.

Authors:  A Jolivet-Gougeon; A Buffet; C Dupuy; J L Sixou; M Bonnaure-Mallet; S David; M Cormier
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

6.  Inguinal lymphadenitis associated with Capnocytophaga bacilli.

Authors:  C C Johnson; J Poupard
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

7.  Development of techniques for the genetic manipulation of the gliding bacterium Cytophaga johnsonae.

Authors:  M J McBride; M J Kempf
Journal:  J Bacteriol       Date:  1996-02       Impact factor: 3.490

8.  Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.

Authors:  Anne Jolivet-Gougeon; Zohreh Tamanai-Shacoori; Laurent Desbordes; Virginie Gandemer; Jean-Louis Sixou; Nolwenn Morvan-Graveline; Michel Cormier; Martine Bonnaure-Mallet
Journal:  BMC Infect Dis       Date:  2005-05-09       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.